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Background: One of the greatest challenges facing scientists today is an understanding 
of genetic factors associated with the development of common, complex diseases such as 
diabetes, depression, and cancer. In addition to symptom burden (effecting quality of 
life), premature death, and disability caused by such diseases, the economic burden to 
society is vastly overwhelming. Last year, Major Depression alone cost nearly $211 Billion 
[USD] to US taxpayers. Yet, these diseases have been incredibly arduous to study due to 
the hundreds of genes that contribute very small effects that lead to disease development. 
We suggest that an alternative model of complex diseases is needed to elucidate the 
causative genetic mechanisms. We exploit a naturally occurring clear phenotype (brindle 
color) present on a simplified genetic background (pet dogs) and analyze large-scale 
genomic variation (CNVs) effecting gene expression (epigenetics – DNA methylation). 
 
Significance: Common, complex disease is a tremendous burden for patients, families, 
and clinicians alike. Elucidation of the genetic mechanisms leading to disease 
development would result in personalized therapies and improved patient outcomes. 
 
Purpose: To identify large-scale genomic variations present in Brindle color dogs and 
determine if epigenetic regulation is leading to phenotype development.  
  
Conceptual Framework: We used the genetic single gene-two hit model (Hussian, 2015) 
to guide this work. This framework combines rare and common variant theories with the 
addition of mutator/anti-mutator modulation to lead to disease development. 
 
Methods: Using a custom-designed aCGH to interrogate genomic structural variation, 
we analyzed 12 dogs of 3 different coat colors (Black, yellow, and brindle). Then, we 
performed genome-wide DNA methylation analysis on a subset of 8 dogs to determine 
the effect genomic variation has on epigenetic silencing of gene expression. 
 
Results: We identified a 67 Kb complex genetic variation (10 probes, p=0.001) that 
disrupts gene expression and is epigenetically silenced in certain skin cells producing 
pigment differences (p=0.04). 
  
Conclusion: Brindle coat color in canines is a complex genetic mechanism involving 
structural changes leading to epigenetic effects. Identifying this mechanism provides the 
first tractability for understanding complex diseases and is particularly exciting as a 
model for identifying such features in human diseases. 
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A Genetic Model of Common, Complex Disease Hints at Genomic Architecture:  
Brindle Coat Color in Canines  
 
INTRODUCTION 
The Problem of Common, Complex Disease 
One of the greatest challenges facing clinical scientists in the 21st century is 
understanding the genetic basis for complex human diseases.1 One prevalent paradigm, 
coined the ‘common disease-common variants’ (CDCV) paradigm, states that genetic 
susceptibility to common disease is due to genetic variants that are relatively frequent in 
general populations and have low penetrance.2 In the early 2000s, this resulted in a then-
revolutionary technique - the Genome-wide Association Study (GWAS) based on single 
nucleotide polymorphism (SNP) frequencies in large populations.3 Yet, GWAS methods 
have not been able to identify the majority of causative variation associated with 
common, complex diseases.4 In fact, within complex diseases, all of the common variants 
(taken together) only explain a very limited proportion of the disease heritability.5 For 
example, schizophrenia has a heritability of 85%, but of the 100 SNPs that have been 
associated with the disease, only a very small percentage of the heritability can be 
explained with ORs on the order of 1.1-1.2.6,7 This has led to the inevitable question, 
“where is the missing heritability?” 
Finding the “Missing Heritability” 
More recently, scientists have begun to believe that this “missing heritability” can 
be explained by copy number variations (CNVs) and epigenetic modifications that are 
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currently unknown.6,8 CNVs are defined as a DNA fragment with variable copies 
compared to a reference genome and can be present in duplication, deletion, inversion 
and translocation and are present in more than 20% of the genome.9,10 The number of 
studies linking CNVs with common complex diseases has increased dramatically in 
recent years.10  
 In addition to the role CNVs have in disease liability, science is just beginning to 
elucidate the role of epigenetics in complex disease. The modern definition of epigenetics 
covers heritable information of gene expression mediated by dynamic mechanisms that 
include DNA-methylation, histone modifications, and noncoding RNAs 11. DNA 
methylation at the 5’ position of cytosine (5-mC) is a key epigenetic mark that is critical 
for various biological and pathological processes and is now considered the “fifth base”.12 
In fact, the "loss of 5-hmC" is considered an epigenetic hallmark of melanoma, with 
diagnostic and prognostic implications in multiple cancer types.13-15  
Studies on the domesticated canine have recently provided new insight on their 
potential as a genetic model. Dogs have many similarities to humans, including genetics 
and certain disease predispositions.16,17 Dogs also have some intriguing differences, such 
as a reduced genetic heterogeneity within breeds combined with increased heterogeneity 
across breeds. This underlies many of the breed-to-breed differences in disease risks; yet 
other traits seem likely to have been purposely introduced by breeders, such as 
chondroplasia 18,19. The unique genetic power of canines can be seen in brindle coat color, 
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a coat color characterized by a pattern of alternating black/brown and red/yellow coat 
color that forms an 
irregular pattern, 
typically a “v” over 
the dorsum and “s” 







encountered by studies of common, complex disease by using a novel animal model (the 
dog), a novel methodological approach (DNA methylation and CNVs), and use a simple 
phenotype (brindle coat color) to understand complex genetic variation.  
Coat Color Basics 
In most mammals, melanocytes synthesize red/yellow (pheomelaninic) or 
black/brown (eumelaninic) color that is governed by two genes: Agouti, which encodes a 
paracrine-signaling ligand secreted by cells adjacent to hair follicle melanocytes, and 
Melanocrtin 1 receptor (MC1R), which encodes a seven trans-membrane receptor that, 
Figure 1: Coat Color in Greyhounds. (A) Light Brindle (Kbr/Ky, Kbr/Kbr) (B) 
Dark Brindle (Kbr/Ky, Kbr/Kbr) (C) Yellow(Ky/Ky) (D) Black(KB/Ky, KB/Kbr, 
KB/KB). Photos courtesy of www.greyhound-data.com. 
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when active, causes melanocytes to produce eumelanin 20. Agouti coat color effects are 
mediated by competitive inhibition of alpha-melanocyte-stimulating hormone binding at 
MC1R. Thus, MC1R loss of function or Agouti gain of function results in production of 
pheomelanin (red/yellow), while MC1R gain of function or Agouti loss of function results 
in production of eumelanin (black/brown).21 However, it was recently revealed that the 
pigment type-switching mechanism in the dog has additional complexity that was 
previously unknown in any species, including the presence of a black coat color that is 
dominant to yellow.20,22 
Candille et al. demonstrated that dominant black is the result of a mutation in the 
beta Defensin 3 gene CBD103.22 Specifically, a three base pair deletion results in loss of a 
single glycine residue (“ΔG23”). That variation has two effects: i) increased extracellular 
levels (mechanism unknown) and ii) increased affinity of CBD103 for MC1R. The 
dominant black effect is mediated by CBD103 inhibition of Agouti binding at MC1R. A 
linkage study first implicated chr16 as the locus for brindle coat color, and as part of this 
analysis Kern et al. were able to define a dominance order of KBlack > KBrindle > KYellow 
(hereafter KB, Kbr, Ky, see Figure 1).20 They postulated that brindle likely results from an 
unstable allele that switches from yellow to black through some epigenetic process. Chen 
et al. subsequently identified common structural variation at the CBD103 locus – directly 
affecting its copy number and having a breakpoint proximal to the gene – and proposed 
BRINDLE COAT COLOR IN CANINES              McNamara, ER. Page 7 of 25 
 
that a structural variant could be responsible for such a Mendelian trait with an epigenetic 
readout.23  
To verify ΔG23 as the causal mutation, Candille et al. generated a transgenic 
mouse model.23  While the ΔG23 mouse was black, unexpectedly 21/23 wildtype KY/KY 
also had black coat color.23 This suggests the possibility that the ΔG23 mutation is not 
necessarily the dominant black mechanism but could instead be a marker of a CBD103 
allele that is expressed at increased levels over wild type. In the same study, brindle coat 
color was mapped to a 1.85 Mb region overlapping CBD103.  
Honor’s Project Purpose 
Characterize DNA methylation patterns of the genomic locus Chr16:58,975,216 
58,976,773 in canine blood and skin tissue. 
Conceptual Framework 
We used the genetic single gene-two hit model to guide this work.24 This 
framework combines rare and common variant theories with the addition of 
mutator/anti-mutator modulation to lead to disease development. 
METHODS 
Ethics Statement 
All research activities were approved by The Ohio State University Animal Use 
and Care Committee (IACUC; Protocol 2010A0025). Protocols were based on the statutes 
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of the Animal Welfare Act and the guidelines of the Public Health Service as issued in the 
Guide for the Care and Use of Laboratory Animals (revised 1996).  
Samples 
The samples used as part of this study were collected under a larger study of breed 
variation and disease association in pure breed dogs. Samples were collected in 
collaboration with The Ohio State University Veterinary Medical Hospital and 
Greyhound Health and Wellness Program. Interested owners were screened for 
inclusion, and subsequently informed consent for blood collection was obtained from the 
owner, and sample collected by a trained veterinary technician in 1-2 7 mL BD lavender 
top tubes. All samples were classified according to breed and known phenotypes. Dogs 
were selected for use in this study based on coat color pattern listed on their registration, 
regardless of known disease status. Dog breeds were excluded from the study if their 
breed was known to have e/e genotypes. Coat colors were subsequently placed into of 
the phenotype categories: KB, Kbr, or Ky. Consequently, all Greyhounds used in further 
analysis were genotype and sequenced. It is noted that Greyhounds are not known to 
have an e/e genotype (that is, dominant melanocortin mutation that would make the dog 
appear to be yellow/red when it may possess the underlying Kbr genotype).  Registration 
and pedigree information was collected and confirmed. 
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DNA/RNA Isolation 
Blood: Genomic DNA was isolated from lleukoctyes using 5 Prime ArchivePure 
DNA Blood Kits (Gaithersburg, MD) as per protocol with an additional ethanol 
precipitation step. Samples were tested for quality using a 2% pre-stained ethidium 
bromide agarose gel with electrophoresis and subsequent fluorescence. Additional 
quality control included measurements with the Nanodrop 2000 and Qubit 3.0 
Fluorometer readings per manufacturer’s protocols. Results demonstrated visualized 
DNA as compact, high-molecular-weight bands with no low-molecular-weight smears 
and OD260/280 ratios ≤1.8 and OD260/230 ratios ≤ 2.0, thus indicating intact high-quality 
genomic DNA.   
RNA: Total RNA was isolated from 5mm skin punches; whenever possible the 
same subject used to generate gDNA was used to generate RNA (with a different skin 
punch). We used the RNeasy Fibrous Tissue Mini Kit (Qiagen) with a tissue pulverizer 
to isolate RNA. When necessary, some samples were placed in RNAlater-ICE frozen 
tissue transition solution. After isolation, SuperScript III First-Strand Synthesis kit 
(Invitrogen) was used to generate cDNA as per their protocol.  
Microarray-based Comparative Genomic Hybridization (aCGH; Agilent) on gDNA 
from Whole Blood 
Platform: Our initial CNV observation was made on the Nimblegen 385K array. 23 
In that study, we identified a 611kb CNV on chr16 which overlapped the known K locus.23 
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Subsequent to this finding, we custom designed our own ultra-high-resolution Canine 
CGH array (Agilent) using Genotypic bioinformatics core to develop probes that covered 
the CanFam2 genome. To avoid cross-hybridization, each probe was aligned to the 
CanFam2 genome using BLAST; any probe that did not map uniquely was removed 
except those targeting segmental duplications. This array includes 1 Million 
oligonucleotide spots with an average spacing of <1.7 kb genome-wide. Additionally, our 
array includes known Segmental Duplications based on Akey’s map of segmental 
duplications, with an average spacing per probe of <1.5 kb.25 Essential for an oligo array, 
this platform uses 50–75mers with the design of the probes to have TM within +/- 3 oC of 
each other. Also, this platform uses 3 µg of DNA without requiring complexity reduction 
or amplification (which generate incomplete sampling and signal noise, respectively). 
The advantage of using the Agilent array compared to other commercially available 
arrays is that Agilent has an excellent low background with increased signal to noise 
ratio. This ratio allows for adequate CNV detection at 3 probes or less on a Agilent 1M 
probe array, compared to >10 probes needed for Nimblegen’s 2.1 M probe.26 All samples 
were two-color comparatively hybridized against the gDNA from a single reference dog, 
a Labrador Retriever. Hybridization to arrays was completed by the BioGenomics Core 
at The Research Institute at Nationwide Children’s Hospital (TRINCH; Columbus, 
OH).  The protocol for DNA digestion, labeling, purification and hybridization to the 
arrays followed the manufacturers' instructions. 
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Data Analysis: Microarray image files were quantified using the Agilent Feature 
Extraction software and then imported into Partek. We set the criteria for calling CNVs 
intentionally low to minimize false negatives and accept false positives. First, a filtering 
procedure was used to flag low-intensity features. Probes with a combined Cy3 and Cy5 
intensity value of more than 3 SD below the mean of the high-intensity mode were 
flagged and excluded from further analysis. Next, segmentation of the remaining data 
was performed using a circular binary algorithm with post-processing to ensure that 
regions had at least three genomic coordinate consecutive probes with the same sign of 
deviation in the log 2 ratio as well as the median log 2 ratio which exceeded 0.3 in absolute 
value on the log scale. A subset of CNVs that had been previously reported were 
manually confirmed within the dataset.  
Call Validation: We validated a subset of the CNV calls made from the 1M Agilent 
array by Southern blotting. We selected 3 CNV overlapping known genes (HMGCS2, 
ZFHX3, SOX9) and 1 reference gene (VEGF, as used previously23 and described 27). 
Briefly, probes were designed to target unique sequence in HindIII fragments that did 
not overlap predicted breakpoints, generate fragments of different sizes to allow 
multiplex hybridizations, and have similar melting temperatures, to result in comparable 
signal in multiplex format. Probes were generated by PCR, confirmed by agarose gel 
electrophoresis, purified using PCR Purification kit (QIAGEN), and random primed 
BRINDLE COAT COLOR IN CANINES              McNamara, ER. Page 12 of 25 
 
labeled with 32P. Signal was quantified by PhosphorImaging (Storm, GE Healthcare Life 
Sciences). 
DNA Methylation with MeDIP 
MethylCap-seq library generation and sequencing: For DNA methylation analysis, we 
selected MethylCap-seq. This is a cost-efficient, genome-wide, highly reproducible, high-
throughput, less cumbersome method then other traditional techniques used for 
interrogating methylated regions.28-30 After fragmentation, methylated DNA is captured 
with the high affinity methyl-CpG binding domain of human MBD2 protein and eluted 
in a step-wise manner indicative of methyl-CpG density.29,30 Consequent analysis is 
performed on the enriched fragments by massively parallel sequencing.28,29 MethylCap-
Seq was performed at The Ohio State University Comprehensive Cancer Center’s 
Genomics Shared Resource. Briefly, gDNA isolated from leukocytes in whole blood was 
quantified by Qubit flurometric quantitation (Life Technologies, Grand Island, NY). 1-1.3 
µg DNA was subjected to fragmentation using a Covaris S2 Adaptive Acoustic 
instrument (Woburn, MA) to average fragment size of 100 – 250 bp. Methylated DNA 
enrichment fragments were enriched using the Diagenode AutoMethylCap Kit 
customized for the Diagenode SX-8G IP-Star Compact Automated System (Denville, NJ). 
1 ng of the resultant enriched and ethanol precipitated methylated DNA was used to 
generate an Illumina-compatible sequencing library using the Kapa Hyper Prep Kit 
(Fremont, CA). Library fragments (average fragment size is 300-400 nt, including 
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adapters) were amplified using Phusion High-Fidelity PCR Master Mix with HF Buffer 
(NEB) for 8 PCR cycles. Library material was purified with Agencourt AMPure XP beads 
(1:1 volume; Beckman Coulter, Inc., Indianapolis, IN). Sequencing was performed on the 
Illumina HiSeq 2500 (San Diego, CA) using the single-end 50-bp approach (Version 3 
chemistry) to a depth of at least 40 million passed filtered reads. 
MethylCap-seq read alignment & assignment of methylation values from reads: 
Sequencing reads were received in fastq format.  Duplicates (i.e., all reads with the same 
sequence data) among passed filter (using default Illumina settings) sequencing reads 
were collapsed. Collapsed reads were quality trimmed using a quality score cutoff of 33 
using the fastx toolkit.  Reads were then aligned to canine genome (CanFam3) using 
bowtie version 0.12.7.29 DNA fragment profiles were extracted for every sample from 
Bioanalyzer data using a custom python script.  These fragment profiles and the aligned 
reads were employed to assign methylation values to every CpG in the human genome 
using PrEMeR-CG.31 We focused on the methylation of first exons of annotated protein 
coding genes, which has been shown to be especially relevant for regulation of gene 
expression.32 Given that this is the first analysis of human DNA methylation changes in 
less than 48 hours in critical care patients, we applied stringent thresholds to the data.  
We removed any regions in which MethMAGE failed (due to absence of methylation 
data), required that the maximum of the methylation signal in the two groups was above 
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its median, and applied Benjamini Hochberg FDR (BHFDR)33 with a q-value cutoff of 
0.01.  
DNA Methylation Validation with Bisulfite sequencing: We used the EZ DNA 
Methylation-Gold kit (Zymo Research) to Bisulfite covert gDNA according to their 
protocol. We then PCR amplified the converted gDNA with primers designed for 
bisulfite converted gDNA to result in amplicons ~400bp with ≥2 CPG islands within 
amplicon using the online database Bisearch.34,35 We then used CloneJET PCR cloning kit 
(Fermentas, Thermo Scientific) with Z-competent DH5α E. Coli cells (Zymo Research). 
After colonies were identified based on the PCR screening, the PCR product was purified 
(QIAGEN), and then sequenced at the DNA sequencing core (Eurofins, MWG, Operon). 
Sequence was then analyzed and figures created using Bisulfite Sequencing DNA 
Methylation Analysis (BISMA) tool available from Bisulfite sequencing Data Presentation 
and Compilation (BDPC).36-38 
Polymerase Chain Reaction (PCR) for Fine-Mapping Structure on Chromosome 16 
 PCR: Using the JumpStart REDTaq DNA Polyermase protocol (Sigma-Aldrich), 
PCR was performed with additional optimizations of each different primer pair reactions. 
PCR primers were custom designed using Oligo Calc Nearest Neighbor based melting 
temperature (TM) calculations,39 and then uniqueness confirmed using the UCSC 
Genome Browser of CanFam2/CanFam3.40,41 Oligos were generated by Integrated DNA 
Technologies (IDT). All sequencing analysis was performed by the DNA sequencing core 
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(Eurofins, MWG, Operon).  
 Digestion, Ligation, Amplification (DLA): DLAPCR walking method, we followed a 
previously described protocol.42 We generated four unique random adaptors not present 
within the genome, and then paired these with rare-cutter restriction enzymes. Final 
Adaptor gDNA was then combined with unique primers from the locus of interest in two 
reactions; the first was an external primer pair amplification followed by an internal PCR 
of the same locus. 
RESULTS 
Previous Work on the Brindle 
Locus 
 Previously, the presence 
of a 611kb CNV-rich region 
overlapping KB locus from 
chr16:61,902,802-62,514,014 
within 8 dogs analyzed using a 
Nimblegen 385k aCGH23 and 
then confirmed to be a 76kb CNV in Brindle dogs (n = 15) using the ultra-high density 1 
M oligonucleotide array CGH (See Figure 2). Using a Southern blot, we were able to 
further define allelic differences in CBD103 (establishing heterozygosity and 
homozygosity);  these results suggested 4 different alleles corresponding to two 
Figure 2: New CNV overlapping K-locus in only brindle dogs. 
The two dogs with a CNV where both registered AKC dogs with 
brindle listed in their coat pattern, from two different breeds (A) 
Akita (B) Bulldog. (C) New partitioning of the CNV and segmental 
duplication in all 8 dogs. Note that the 6 dogs share a portion of the 
segmental duplication. 
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different alleles in black, one for brindle, and one for yellow. We then used overlapping 
PCR assays to scan the full 6.6 kb region within the restriction enzyme cleavage sites 
and computationally identified a statistically significant purported promoter, CTCF 
epigenetic insulator, and open reading frame.  This leads to the possibility of an 
antisense transcript affecting the type switching in brindle coat color. 
 
Work on the 
Brindle Locus 
for this Project 





we identified 2 
regions of the first exon of CBD103 that were differentially methylated (Brindle Vs 
Fawn, p = 0.036; Brindle Vs Black, p= 0.037).  
 Based on our previous work, we hypothesized that epigenetical regulation is 
involved in the color type-switching and maintenance in brindle.20 We isolated genomic 
DNA from the skin of black, yellow, dark brindle and light brindle stripes of dogs. We 
Figure 3: Bisulfite Methylation Results. (A) Each column corresponds to a CpG 
(3 total) overlapping the CTCF locus, with each row representing a clone. Here, we 
demonstrate that in Kyellow, each CpG is methylated; in KbrLight we have methylation 
of 2 of the 3 CPGs (a single point mutation making it unusable for determining 
methylation status of the center CpG). For KbrDark, we find methylation of the first 
CpG, but no methylation thereafter. (B) A direct comparison of the CTCF locus in 
light and dark brindle stripes from the same dog.     
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conducted Bisulfite Conversion and Sequencing (see Figure 3).  
 We custom-designed PCR primers for amplicons upstream and downstream of both 
the CTCF site and CBD103.34,35 We cloned the bisulfite converted PCR product and 
sequenced the appropriately sized clones. Interestingly, we found differential patterns of 
methylation. In light brindle and yellow, we found methylation that existed after the 
CTCF site and at CBD103. But in dark brindle and black skin, we found no DNA 
methylation of the CTCF locus or CBD103. 
DISCUSSION 
Brindle coat pattern has been hypothesized to be the product of a binary 
(yellow/black) type-switching allele that i) manifests no later than early neural crest 
differentiation of melanocyte lineage cells and ii) is generated and maintained 
epigenetically,20 but the exact mechanism has remained elusive. This is largely due to an 
abundance of highly repetitive elements in the locus, which has resulted in putative 
genome assembly errors and hindered determination of the genetic variation that differs 
between K alleles. Here, we present work that gives insight into the complex mechanism 
of brindle coat pattern in dogs. The nature of the genetic mechanism underlying brindle 
is reminiscent of X-inactivation in mammals (reviewed in 43). There, two non-coding 
genes, Tsix and Xist, act in cis and their expressed RNAs are localized to the nucleus. X-
inactivation is mediated by the coating of one X chromosome with Xist RNA. After the 
initiation of X-inactivation, Tsix – which is proximal, in an antisense position to Xist – 
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expression is downregulated, creating a permissive state for Xist upregulation by 
activators (see Figure 4.)   
 Tsix RNA associates with the methyltransferase DNA methyltransferase 3A 
(DNMT3A), either directly or through accessory factors, and thereby stably silences the 
Xist promoter via DNA methylation and other changes in chromatin structure. 44,45 The 
key mechanism that regulates this program is the binding of CTCF exclusively to the Tsix 
locus of the inactivated X chromosome. That is associated with increased expression of 
that copy of 
Tsix through 
the Xist locus, 
somehow 
silencing it. On 
the active X, 
the same CTCF 
site is 
methylated and Tsix is not expressed. The evidence we have accumulated suggests the 
same mechanism as is seen in random X-inactivation, except that both copies of a brindle 
homozygote are either activated or inactivated.  
 
 
Figure 4: A model of a regulatable epigenetic switch created by CTCF and Tsix. Xi 
represents the inactive X chromosome. Xa is the active chromosome. Modified 
from.43 
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Research Implications 
The clearer understanding of the brindle mechanism presented here has potential 
implication in the current studies of common, complex diseases in the human 
population. Much of the previous research to date has identified low or rare minor 
allele frequencies (MAF) in association with such diseases rather than single-gene 
associations.46 Contrarily, research focused on CNVs in the human genome has revealed 
that many significant genetic elements are overlapped by these structural variants, 
including approximately 85.01% of exons.47  
Clearly, there was is much additional work to be completed to fully elucidate the 
exact mechanism at the Brindle locus (Including functional and biochemical studies). Our 
understanding of this mechanism demonstrates the potential effect of copy number 
variations on gene expression, as well as the feasibility of functional effects in the human 
genome. Similar genetic architecture in humans may hint at plausible new explanations 
of disease and trait development. It also seems likely that these phenomena can be 
exploited as genetic tools for diverse applications of genetic/epigenetic therapeutics.  
Clinical Implications for Nursing 
 Nurses in the clinical setting are often responsible for medication administration 
in the treatment and management of common, complex diseases. As targeted therapies 
based on genetic profiles become more common, nursing practice must evolve to 
encompass not only the genetics/epigenetics of individuals during diagnoses, but also the 
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genetics/epigenetics that affect therapeutic responses to treatment. Appropriate advances 
in practice will be necessitated at the individual nurse level to guide institutional 
implementations of patient education related to genetically based treatment regimens.48  
One clear way nurses can be on the forefront of this era of genomic-guided health 
is through increasing nurse knowledge of pharmacogenomics to build a platform for 
nurses to promote its use among their patient population, network with other providers, 
work closely with pharmacists and assess patients for eligibility.49 
Nurses play a large part in patient education, when patients are faced with making 
decisions based on genetic information they assist with education, counseling, and 
emotional support. Nurses need to be aware of trends in genetic advancements with 
regard to how they relate to the individual care of each patient.50 
 There is also a demonstrated need for additional education for nurses themselves 
regarding genetic advancements. Nursing students report a perceived lack of comfort 
with both knowledge and clinical applications of genetics.51 On the other hand, practicing 
RNs also report benefits from additional education regarding the role of genetics and 
genomics in patient health outcomes. Nurses’ unique position allows them great 
potential to translate such genomic discoveries into more personalized interventions and 
assessment for patients.50  
CONCLUSION 
This model of the brindle coat color mechanism in dogs serves to clarify this 
unique framework for potential screening, development, and treatment of disease.  
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